Prior to the identification of MECP2 mutation as the main cause of Rett syndrome, early research into the pathology of the syndrome identified that reduction of levels of biogenic amines and their metabolites was a common feature; however biogenic amines were not correlated with anxiety levels (He et al., 2014; Roux and Villard, 2010). Here, MECP2 is linked to Rett syndrome.